Chen Hua, Dai Zhuling, Huang Guohua, Yang Shuqin, Qian Liang, Luo Qiao, Li Jianjun, Su Qin, Shu Xiaojuan, Fu Xiuyan, Wang Yinyan, Xia Yuqing, Wang Li, Deng Taibing, Wen Junjie
The People's Hospital of Guang'an Guang'an, Sichuan, China.
Guang'an Vocational and Technical College Guang'an, Sichuan, China.
Am J Transl Res. 2024 Apr 15;16(4):1468-1476. doi: 10.62347/KYKR6707. eCollection 2024.
The purpose of this study was to elucidate the impact of cardiopulmonary rehabilitation nursing on the pulmonary function, sleep quality, and living ability of patients afflicted with Coronavirus Disease 2019 (COVID-19).
A total of 98 patients with COVID-19 treated at The People's Hospital of Guang'an between September 2021 and January 2023 were retrospectively collected as the research subjects. Among them, 48 patients who received standard nursing care from September 2021 to September 2022 were set as the control group, and 50 patients who underwent cardiopulmonary rehabilitation nursing from October 2022 to January 2023 were set as the research group. The pulmonary function indicators [including Forced Expiratory Volume in 1 second (FEV1) and Left Ventricular Ejection Fraction (LVEF)], sleep quality [evaluated using the Pittsburgh Sleep Quality Index (PSQI)], and living ability [assessed by the 36-Item Short Form Survey (SF-36) scale] pre- and post-intervention were compared between the two groups.
Pre-intervention, FEV1, LVEF, PSQI scores, inflammatory factor levels [C-reactive protein (CRP), procalcitonin (PCT)], and SF-36 scores showed no significant differences between the two groups (>0.05). Post-intervention, the research group exhibited notably enhanced FEV1 and LVEF, lower PSQI scores, lower CRP and PCT, and higher SF-36 scores compared with the control group, with statistical significance (<0.05). Multifactorial logistic regression analysis showed that non-receipt of cardiopulmonary rehabilitation, age ≥60 years, concurrent respiratory failure, coexistent heart failure, and acid-base imbalance were independent risk factors of adverse outcomes in COVID-19 patients (P<0.05).
Application of cardiopulmonary rehabilitation nursing in COVID-19 patients can significantly improve pulmonary function, sleep quality, and overall quality of life, and relieve the inflammatory state of the patients, thereby enhancing prognosis. This approach has certain value of popularization and application.
本研究旨在阐明心肺康复护理对2019冠状病毒病（COVID-19）患者肺功能、睡眠质量和生活能力的影响。
回顾性收集2021年9月至2023年1月在广安市人民医院治疗的98例COVID-19患者作为研究对象。其中，将2021年9月至2022年9月接受标准护理的48例患者设为对照组，将2022年10月至2023年1月接受心肺康复护理的50例患者设为研究组。比较两组干预前后的肺功能指标[包括第1秒用力呼气量（FEV1）和左心室射血分数（LVEF）]、睡眠质量[采用匹兹堡睡眠质量指数（PSQI）评估]和生活能力[通过36项简短健康调查（SF-36）量表评估]。
干预前，两组的FEV1、LVEF、PSQI评分、炎症因子水平[C反应蛋白（CRP）、降钙素原（PCT）]和SF-36评分比较，差异无统计学意义（>0.05）。干预后，研究组的FEV1和LVEF明显提高，PSQI评分降低，CRP和PCT降低，SF-36评分高于对照组，差异有统计学意义（<0.05）。多因素logistic回归分析显示，未接受心肺康复、年龄≥60岁、并发呼吸衰竭、并存心力衰竭和酸碱失衡是COVID-19患者不良结局的独立危险因素（P<0.05）。
对COVID-19患者应用心肺康复护理可显著改善肺功能、睡眠质量和整体生活质量，缓解患者的炎症状态，从而改善预后。该方法具有一定的推广应用价值。
